BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23678162)

  • 21. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Takakura M; Shimizu M; Irabu H; Sakumura N; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Immunol; 2019 Nov; 208():108252. PubMed ID: 31449879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA.
    Vastert SJ; Prakken BJ
    Nat Rev Rheumatol; 2014 Nov; 10(11):640-2. PubMed ID: 25201384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era.
    Ailioaie LM; Ailioaie C; Litscher G
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease.
    Brown RA; Henderlight M; Do T; Yasin S; Grom AA; DeLay M; Thornton S; Schulert GS
    Front Immunol; 2018; 9():2995. PubMed ID: 30619348
    [No Abstract]   [Full Text] [Related]  

  • 25. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
    Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
    Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Pediatr Res; 2020 Dec; 88(6):934-939. PubMed ID: 32184444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.
    Chen G; Deutsch GH; Schulert GS; Zheng H; Jang S; Trapnell B; Lee PY; Macaubas C; Ho K; Schneider C; Saper VE; de Jesus AA; Krasnow MA; Grom A; Goldbach-Mansky R; Khatri P; Mellins ED; Canna SW
    Arthritis Rheumatol; 2022 Jul; 74(7):1271-1283. PubMed ID: 35189047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of interferon-gamma levels may lead to earlier diagnosing macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Lu M; Teng L; Xu Y; Xu X
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):115. PubMed ID: 37828529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performances of the "MS-score" And "HScore" in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients.
    Sag E; Keskin A; Atalay E; Demir S; Cuceoglu MK; Akca UK; Batu ED; Bilginer Y; Ozen S
    Rheumatol Int; 2021 Jan; 41(1):87-93. PubMed ID: 33215249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma exchange successfully treated macrophage activation syndrome in rheumatoid factor-positive polyarticular juvenile idiopathic arthritis with co-existing pneumonia.
    Shi L; Hu F; Xu C; Zhu H; Qie D; Yuan C; Tao Y; Liu H
    Int J Rheum Dis; 2018 May; 21(5):1142-1145. PubMed ID: 28328098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report.
    Zeng P; Li F; Zeng H
    Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.
    Mizuta M; Shimizu M; Irabu H; Usami M; Inoue N; Nakagishi Y; Wada T; Yachie A
    Rheumatology (Oxford); 2021 Jan; 60(1):231-238. PubMed ID: 32681176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children.
    Aydın F; Çelikel E; Ekici Tekin Z; Coşkun S; Sezer M; Karagöl C; Kaplan MM; Tekgöz N; Kurt T; Özcan S; Kavurt AV; Özkaya Parlakay A; Çelikel Acar B
    Int J Rheum Dis; 2021 Apr; 24(4):542-547. PubMed ID: 33550678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.
    Ravelli A; Grom AA; Behrens EM; Cron RQ
    Genes Immun; 2012 Jun; 13(4):289-98. PubMed ID: 22418018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
    Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
    Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.
    Noto T; Seto H; Fukuhara J; Murabayashi M; Yachie A; Ayusawa M; Morioka I
    BMC Pediatr; 2018 Dec; 18(1):386. PubMed ID: 30541507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis.
    Ling XB; Macaubas C; Alexander HC; Wen Q; Chen E; Peng S; Sun Y; Deshpande C; Pan KH; Lin R; Lih CJ; Chang SY; Lee T; Sandborg C; Begovich AB; Cohen SN; Mellins ED
    BMC Med; 2012 Oct; 10():125. PubMed ID: 23092393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: analysis of 13 patients].
    Shi H; Wang HW; Cheng PX; Hu XF; Liu QJ; Wan LJ
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):812-7. PubMed ID: 17274866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.